Clinical Microbiology: Open Access

A new and effective treatment for dengue fever

3^rd International Conference on Clinical Microbiology & Microbial Genomics

September 24-26, 2014 Valencia Convention Centre, Spain

Max Reynolds

Keynote: Clin Microbial

Abstract:

For over the last 50 years plus the scientific world has been trying to find a way to stop dengue fever without much success until now. The problem has been to kill all 4 different strains of the virus which cause this disease without injuring the patient in the process. There have been some major expensive failures in the arena of vaccine production. Now we have a specialist Australian based company who has developed, from a plant extract, a compound which kills all 4 strains and is safe for human use. The author and his team have carried out all 3 phase studies successfully over the last 8 years and have most recently achieved, in a Double Blind 540 patients trial at the University of Airlungga in Indonesia, have achieved a 96.6% kill rate of all 4 virus within 3 days and at the same time increased the CD4 (helper cells) and CD8 (killer cells) immune elements within the patients by 64.4%. These results have been achieved by the use of a plant extract from the Melaleuca alternifolia tree, a native of Australia, from which they have removed, by a patented system, 90% of the mono terpenes and made the active compounds safe for human oral consumption. The compounds dissolve the outer envelope which covers the virus and then proceeds to kill the virus directly. With this drug dengue will be a disease of the past as soon as it reaches the worlds medical centers where dengue is of major importance.

Biography :

Max Reynolds has over half a century of global experience in scientific research, business and product development. His commitment and determination to exploring biotechnology and discovering new practical uses for it has led to many advances, including the development of 98alive?, which is produced by 98 Alive Pty Ltd of which Professor Reynolds is also the Managing Director. He has previously lectured at leading Australian university, Griffith University in Brisbane, Queensland and has held the position of Director of the Program in Australasia Botanical Medicine for Population Health.